Included in the formulation
АТХ:V.09.G.A Compounds of technetium 99m
Pharmacodynamics:Does not have a pharmacological effect when used in recommended dosages.
Pharmacokinetics:The maximum concentration in the myocardium is reached after 5 minutes and remains for 4 hours.
The elimination half-life is 6 hours. Elimination by the kidneys for 48 hours.
Indications:It is used to diagnose blood flow in the myocardium.
XXI.Z00-Z13.Z03 Medical surveillance and evaluation in case of suspected disease or pathological condition
Contraindications:Individual intolerance.
Pregnancy and lactation:Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.
Dosing and Administration:Intravenous for 185-250 MBq, then after 4 hours - 500-750 MBq.
The highest daily dose: 1000 MBq.
The highest single dose: 250 MBq.
Side effects:Nausea, fever, impaired sense of smell, transient leukocytosis.
Allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:When used simultaneously with blockers of slow calcium channels and β-adrenoblockers, it is possible to obtain false negative test results.
Special instructions:The use of the drug is possible only in a specialized hospital.